Abstract
The study objective was to evaluate the occurrence of sensorineural hearing loss (SNHL) in patients with Behcet’s disease (BD), looking at potential correlations with specific demographic, clinical, and therapeutic features. Forty-four consecutive patients (15 males, 29 females) fulfilling the International Study Group (ISG) and/or the International Criteria for Behçet’s Disease (ICBD) were enrolled. The endpoints of the study consisted in identifying a deflection of at least 25 dB on pure-tone audiometry and performing statistical analysis to evaluate demographic, clinical, or therapeutic differences between patients with and without SNHL. Our patients showed a mean age ± SD of 45.43 ± 14.05 years; a mean age at disease onset ± SD of 31.54 ± 15.53 years; a disease duration ± SD of 13.89 ± 9.15 years. SNHL was highlighted in 28 (63 %) patients representing the fourth most frequent clinical manifestation in our group of patients. Otologic involvement was significantly more frequent among subjects fulfilling ISG criteria than in patients fulfilling ICBD criteria (p = 0.04). Regarding correlations with BD manifestations, SNHL was significantly associated with cutaneous plus articular involvement (p = 0.013). Conversely, detached analysis of articular and skin manifestations led to no significant differences (p = 0.085 and p = 0.067). No further significant correlations were found between SNHL and BD clinical features or previous or concomitant treatments. Hearing loss was the fourth most common clinical feature in our patients and probably represents an underrated aspect of BD. Hearing impairment was significantly associated with cutaneous plus articular involvement, suggesting the importance of an otologic evaluation in such patients.
Similar content being viewed by others
References
Pineton de Chambrun M, Wechsler B, Geri G, Cacoub P, Saadoun D (2012) New insights into the pathogenesis of Behçet’s disease. Autoimmun Rev 11:687–698
McGonagle D, McDermott MF (2006) A proposed classification of the immunological diseases. PLoS Med 3:e297
Yazici H, Ugurlu S, Seyahi E (2012) Behçet syndrome: is it one condition? Clin Rev Allergy Immunol 43:275–280
Behçet H, Matteson EL (2010) On relapsing, aphthous ulcers of the mouth, eye and genitalia caused by a virus. 1937. Clin Exp Rheumatol 28:S2–S5
Zeidan MJ, Saadoun D, Garrido M, Klatzmann D, Six A, Cacoub P (2016) Behçet’s disease physiopathology: a contemporary review. Auto Immun Highlights 7:4
Kural-Seyahi E, Fresko I, Seyahi N, Ozyazgan Y, Mat C, Hamuryudan V, et al. (2003) The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore) 82:60–76
International Team for the Revision of the International Criteria for Behçet’s Disease (ITR-ICBD). The International Criteria for Behçet’s Disease (ICBD) (2014) A collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol 28:338–347
Lopalco G, Lucherini OM, Vitale A, Talarico R, Lopalco A, Galeazzi M, et al. (2015) Putative role of serum amyloid-a and proinflammatory cytokines as biomarkers for Behcet’s disease. Medicine (Baltimore) 94:e1858
Cantarini L, Pucino V, Vitale A, Talarico R, M Lucherini O, Magnotti F, et al. (2016) Immunometabolic biomarkers of inflammation in Behçet’s disease: relationship with epidemiological profile, disease activity and therapeutic regimens. Clin Exp Immunol 184:197–207
Vitale A, Rigante D, Lopalco G, Brizi MG, Caso F, Franceschini R, et al. (2014) Serum amyloid-A in Behçet’s disease. Clin Rheumatol 33:1165–1167
Sarr SA, Fall PD, Mboup MC, Dia K, Bodian M, Jobe M (2015) Superior vena cava syndrome revealing a Behçet’s disease. Thromb J 13:7
Lai C, Sun Y, Wang J, Purvin VA, He Y, Yang Q, et al. (2015) Optic perineuritis in Behçet disease. J Neuroophthalmol 35:342–347
Morgan ML, Espino Barros Palau A, Lee AG, Foroozan R, et al. (2015) Neuro-Behçet disease presenting with oculopalatal tremor. J Neuroophthalmol 35:51–53
White AS, Taylor RL, McNeill C, Garsia R, Welgampola MS (2014) Behçet’s disease presenting as a peripheral vestibulopathy. J Clin Neurosci 21:1060–1063
International Study Group for Behçet’s Disease (1990) Criteria for diagnosis of Behçet’s disease. Lancet 335:1078–1080
Kobayashi M, Ito M, Nakagawa A, Matsushita M, Nishikimi N, Sakurai T, et al. (2000) Neutrophil and endothelial cell activation in the vasa vasorum in vasculo-Behçet disease. Histopathology 36:362–371
Dagli M, Eryilmaz A, Tanrikulu S, Aydin A, Gonul M, Gul U, et al. (2008) Evaluation of cochlear involvement by distortion product otoacoustic emission in Behçet’s disease. Auris Nasus Larynx 35:333–337
AK E, Harputluoglu U, Oghan F, Baykal B (2004) Behçet’s disease and hearing loss. Auris Nasus Larynx 31:29–33
Hatemi G, Seyahi E, Fresko I, Talarico R, Hamuryudan V (2015) Behçet’s syndrome: a critical digest of the 2014–2015 literature. Clin Exp Rheumatol 33:S3–14
Alajouanine T, Castaigne P, Lhermitte F, Cambier J, Gautier JC (1961) The meningoencephalitis of Behcet’s disease. Presse Med 69:2579–2572
Kulahli I, Balci K, Koseoglu E, Yuce I, Cagli S, Senturk M (2005) Audio-vestibular disturbances in Behcet’s patients: report of 62 cases. Hear Res 203:28–31
Aslan S, Serarslan G, Savas N, Teksoz E, Dagli S (2010) Hearing loss in patients with Behçet’s disease: an audiological and transient evoked otoacoustic emission study. J Laryngol Otol 124:10–15
Sonbay ND, Saka C, Tatlican S, Vuralkan E, Aygener N, Eren C, et al. (2014) Audiological evaluation in patients with Behçet’s disease. J Laryngol Otol 128:694–697
Erbek S, Erbek SS, Yilmaz S, Yucel E, Ozluoglu LN (2008) Vestibular evoked myogenic potentials in Behcet’s disease. Eur Arch Otorhinolaryngol 265:1315–1320
Süslü AE, Polat M, Köybaşi S, Biçer YO, Funda YO, Parlak AH (2010) Inner ear involvement in Behçet’s disease. Auris Nasus Larynx 37:286–290
Diri E, Mat C, Hamuryudan V, Yurdakul S, Hizli N, Yazici H (2001) Papulopustular skin lesions are seen more frequently in patients with Behçet’s syndrome who have arthritis: a controlled and masked study. Ann Rheum Dis 60:1074–1076
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The local ethics committee approved the study and informed consent was obtained by all participants.
Disclosures
None.
Funding
None
Rights and permissions
About this article
Cite this article
Sota, J., Vitale, A., Orlando, I. et al. Auditory involvement in Behcet’s disease: relationship with demographic, clinical, and therapeutic characteristics. Clin Rheumatol 36, 445–449 (2017). https://doi.org/10.1007/s10067-016-3367-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-016-3367-x